IP Verse

Secerna Llp opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Secerna Llp

Patent Number:
EP4011915
Title:
Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist
Applicant:
REGENERON PHARMACEUTICALS, INC.
Opposition Date:
Jul 10, 2024
Patent Number:
EP3470432
Title:
Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist
Applicant:
REGENERON PHARMACEUTICALS, INC.
Opposition Date:
Jul 5, 2022
Patent Number:
EP2872171
Title:
Toxicity Management For Anti-Tumor Activity Of Cars
Applicant:
THE CHILDREN'S HOSPITAL OF PHILADELPHIA
Opposition Date:
Oct 5, 2021
Patent Number:
EP3338794
Title:
Toxicity Management For Anti-Tumor Activity Of Cars
Applicant:
THE CHILDREN'S HOSPITAL OF PHILADELPHIA
Opposition Date:
Nov 26, 2020
Patent Number:
EP3312196
Title:
Antibodies Against Cd38 For Treatment Of Multiple Myeloma
Applicant:
GENMAB A/S
Opposition Date:
Apr 16, 2020
Patent Number:
EP2535355
Title:
Antibodies Against Cd38 For Treatment Of Multiple Myeloma
Applicant:
GENMAB A/S
Opposition Date:
Oct 1, 2019

Competitors of Secerna Llp

GENMAB A/S

REGENERON PHARMACEUTICALS, INC.

SANOFI BIOTECHNOLOGY

Want to track Secerna Llp?

Feel free to send us a message here and we will get back to you